Other common name(s): pencil cactus, pencil tree, milkbush, petroleum plant
Scientific/medical name(s): Euphorbia tirucalli, Euphorbia viminalis, Euphorbia insulana
Aveloz is the Spanish name for a succulent shrub that grows in the tropical areas of Africa, Brazil, and Madagascar. This relative of the poinsettia is sometimes grown as a houseplant. The sap, leaves, and root of various species of the shrub have been used in folk medicine for centuries.
Aveloz sap is promoted for use as an anticancer agent. However, laboratory and animal studies do not support this claim. In fact, they suggest that aveloz sap may actually suppress the immune system, promote tumor growth, and lead to the development of certain types of cancer.
The sap can burn the skin, damage the eyes, and even cause blindness. If taken internally, it can cause burning of the mouth and throat, vomiting, diarrhea, and other serious problems.
How is it promoted for use?
The sap of the aveloz shrub has been promoted as a tumor-killing agent for people with cancer. It is promoted for use on the skin or to be taken by mouth. It is said to burn off warts, cysts, and skin cancers, especially on the face. In various parts of the world, the plant is also used to treat leprosy, earache, abscesses, toothaches, asthma, colic, cough, rheumatism, and fractures.
What does it involve?
In the United States, aveloz is sold in liquid form by some health food stores and herbal practitioners. To treat cancer, benign tumors, warts, and cysts, practitioners recommend drinking five drops of the liquid dissolved in half a glass of water or tea. Aveloz is also sold as an ointment to be applied directly to warts, skin growths, and tumors.
What is the history behind it?
In some tropical areas of Africa, Euphorbia tirucalli has long been recognized as a fish poison. The plants are crushed and placed into rivers so that fish can be easily caught when they float to the surface.
Thousands of years ago, Amazon Indians in Brazil began applying the sap of the aveloz plant to warts and tumors on the skin. By the 1770s, it was used against cancerous tumors in African folk medicine. In the 1880s, a Brazilian physician introduced the plant to conventional medicine.
In the 1970s, some U.S. tabloids began proclaiming aveloz as a cure for cancer when taken internally, saying, "One drop of sap, diluted in a glass of distilled water and taken by the tablespoon every hour, eliminates cancerous growths in one week." The craze over aveloz as a cure for cancer peaked in the 1980s, but it is still sold at some Internet sites as an alternative treatment for cancer.
What is the evidence?
The effects of aveloz have only been studied in the laboratory and in animals, but the results suggest that aveloz may actually promote tumor growth. These early studies suggested that the sap and the plant itself may suppress the body's immune system, making it less resistant to infections and some types of cancer. This may lead to an activation of the Epstein-Barr virus (the same virus that causes mononucleosis) and the development of a type of cancer known as Burkitt lymphoma. In light of this information, no recent cancer studies in humans have been completed on this plant.
One study suggests that chemicals from Euphorbia tirucalli may enhance the immune system of mice with cancer. However, no human studies have been published. Some studies in the lab are still going on to find out how these chemicals affect human cells. Extensive testing will be necessary to determine whether any of these extracts might be suitable for human use. At present, research seems more focused on the use of the sap to kill mosquitoes in the larval stage.
There are many kinds of plants in the Euphorbia genus, some of which are being tested for use against leukemia. Certain extracts look promising in laboratory experiments.
Are there any possible problems or complications?
Aveloz sap can cause chemical burns, making blisters or ulcers on skin and mucous membranes (the moist pink layer of cells that lines the eyes, nose, mouth, and other openings of the body). Sap from the plant can irritate skin and damage the eyes. Blindness has even been reported after untreated eye exposure.
If taken internally, the plant or its sap can cause burning of the mouth and throat, nausea, vomiting, diarrhea, and stomach cramps. It has been reported to have caused some deaths in eastern Africa. Children and pets may be harmed if they eat the plants or sap.
Relying on this type of treatment alone and avoiding or delaying conventional medical care for cancer may have serious health consequences.
More information from your American Cancer Society
The following information on complementary and alternative therapies may also be helpful to you. These materials may be found on our Web site (www.cancer.org) or ordered from our toll-free number (1-800-ACS-2345).
The ACS Operational Statement on Complementary and Alternative Methods of Cancer Management
Eke T. Euphorbia sap keratouveitis. Br J Ophthalmol.1997;81:518.
Euphorbiaceae -10 euphorbia ramosissima- euphorbia virosa (spurge family). Botanical Dermatology Data Base Web site. Accessed at www.botanical-dermatology-database.info/BotDermFolder/EUPH-10.html on April 1, 2011.
Fürstenburger G, Hecker E. On the active principles of the Euphorbiaceae, XII. Highly unsaturated irritant diterpene esters from Euphorbia tirucalli originating from Madagascar. J Nat Prod. 1986;49:386-397.
Hsueh KF, Lin PY, Lee SM, Hsieh CF. Ocular injuries from plant sap of genera Euphorbia and Dieffenbachia. J Chin Med Assoc. 2004;67:93-98.
Imai S, Sugiura M, Mizuno F, et al. African Burkitt’s lymphoma: a plant, Euphorbia tirucalli, reduces Epstein-Barr virus-specific cellular immunity. Anticancer Res. 1994;14:933-936.
Llanes-Coronel DS, Gámez-Díaz LY, Suarez-Quintero LP, et al. New promising Euphorbiaceae extracts with activity in human lymphocytes from primary cell cultures. Immunopharmacol Immunotoxicol. 2010 Jul 29.
MacNeil A, Sumba OP, Lutzke ML, et al. Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br J Cancer. 2003;88:1566-1569.
Neuwinger HD. Plants used for poison fishing in tropical Africa. Toxicon. 2004;44:417–430.
Osato T, Mizuno F, Imai S, et al. African Burkett’s lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia tirucalli. Lancet. 1987;1:1257-1258.
Rahuman AA, Gopalakrishnan G, Venkatesan P, Geetha K. Larvicidal activity of some Euphorbiaceae plant extracts against Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae). Parasitol Res. 2008 Apr;102(5):867-73.
Tyler VA. Aveloz. Quackwatch Web site. Accessed at www.quackwatch.org/01QuackeryRelatedTopics/DSH/aveloz.html on April 1, 2011.
Valadares MC, Carrucha SG, Accorsi W, Queiroz ML. Euphorbia tirucalli L. modulates myelopoiesis and enhances the resistance of tumour-bearing mice. Int Immunopharmacol. 2006;6:294–299.
van den Bosch CA. Is endemic Burkitt’s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol. 2004;5:738-748.
Note: This information may not cover all possible claims, uses, actions, precautions, side effects or interactions. It is not intended as medical advice, and should not be relied upon as a substitute for consultation with your doctor, who is familiar with your medical situation.
Last Revised: 04/01/2011